| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 3686 |
| 1 | GOLIMUMAB | 1858 |
| 2 | GUSELKUMAB | 1793 |
| 3 | LEVONORGESTREL | 1026 |
| 4 | COPPER | 1025 |
| 5 | USTEKINUMAB | 751 |
| 6 | SUMATRIPTAN | 280 |
| 7 | SUMATRIPTAN SUCCINATE | 278 |
| 8 | SOMATROPIN | 195 |
| 9 | SECUKINUMAB | 187 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 1858 | 0.1475 |
| 1 | ETONOGESTREL | 3686 | 0.0640 |
| 2 | GUSELKUMAB | 1793 | 0.0469 |
| 3 | COPPER | 1025 | 0.0238 |
| 4 | PEGFILGRASTIM | 177 | 0.0148 |
| 5 | SUMATRIPTAN SUCCINATE | 278 | 0.0107 |
| 6 | SUMATRIPTAN | 280 | 0.0073 |
| 7 | USTEKINUMAB | 751 | 0.0073 |
| 8 | ADALIMUMAB-AFZB | 16 | 0.0060 |
| 9 | LEVONORGESTREL | 1026 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 4720 |
| 1 | Interleukin-23 Antagonist [EPC] | 2551 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1944 |
| 3 | Progestin-containing Intrauterine System [EPC] | 1026 |
| 4 | Copper-containing Intrauterine Device [EPC] | 1025 |
| 5 | Interleukin-12 Antagonist [EPC] | 751 |
| 6 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 275 |
| 7 | Leukocyte Growth Factor [EPC] | 197 |
| 8 | Interleukin-17A Antagonist [EPC] | 191 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 171 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 2551 | 0.0244 |
| 1 | Copper-containing Intrauterine Device [EPC] | 1025 | 0.0207 |
| 2 | Progestin [EPC] | 4720 | 0.0162 |
| 3 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 275 | 0.0109 |
| 4 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 5 | Interleukin-12 Antagonist [EPC] | 751 | 0.0072 |
| 6 | Interleukin-17A Antagonist [EPC] | 191 | 0.0051 |
| 7 | Thymic Stromal Lymphopoietin Blocker [EPC] | 18 | 0.0026 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 1944 | 0.0019 |
| 9 | Antiseptic [EPC] | 8 | 0.0018 |